(Q54029918)

23 May 2018

title

Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes. (English)

1 reference

23 May 2018

0 references

0 references

1 reference

1 reference

Cheetham C

1

1 reference

23 May 2018

Collis J

2

1 reference

23 May 2018

O'Driscoll G

3

1 reference

23 May 2018

Stanton K

4

1 reference

23 May 2018

Taylor R

5

1 reference

23 May 2018

Green D

6

1 reference

23 May 2018

language of work or name

English

0 references

publication date

1 November 2000

1 reference

23 May 2018

Journal of the American College of Cardiology

published in

1 reference

23 May 2018

volume

36

1 reference

23 May 2018

issue

5

1 reference

23 May 2018

page(s)

1461-1466

1 reference

23 May 2018

Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Reversing endothelial dysfunction with ACE inhibitors. A new trend

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Angiotensin receptor antagonists: focus on losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Losartan, an orally active angiotensin (AT1) receptor antagonist: a review of its efficacy and safety in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Endothelium-mediated vasodilation during ACE inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Endothelium-Derived Relaxing Factors and Converting Enzyme Inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Bradykinin and the therapeutic actions of angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Mechanism by which quinapril improves vascular function in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Cellular and molecular mechanisms of endothelial cell dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Tetrahydrobiopterin metabolism in the streptozotocin induced diabetic state in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2900933-5

7 January 2021

10.1016/S0735-1097(00)00933-5

Identifiers

DOI

1 reference

23 May 2018

PubMed ID

11079643

1 reference

23 May 2018